We report a 28-year-old Asian male patient, known for ITP and in partial remission for eighteen months, who presented to emergency department with ITP relapse (platelets count of 1 × 10^3 /uL), four days after receiving the second dose of Pfizer SARS-CoV-2 vaccine, which required treatment with intravenous immunoglobulins and dexamethasone, we discuss as well the likely underlying pathophysiology and the suggested approach in patients known for ITP who are willing to receive mRNA COVID vaccines.
Informação da revista
Vol. 43. Núm. S3.
Páginas S46 (Novembro 2021)
Vol. 43. Núm. S3.
Páginas S46 (Novembro 2021)
PLATELET DISEASESPP 36
Open Access
IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
Visitas
965
Hana Qasim
Hamad Medical Corporation
Este item recebeu
Informação do artigo
Suplemento especial
Case report
O texto completo está disponível em PDF